[CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENTS HAVE BEEN
REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION.]
SPONSORED RESEARCH AGREEMENT
This Sponsored Research Agreement (“ Agreement ”) is entered into as of the Effective Date by and between Cell
Therapeutics, Inc., a Washington corporation with offices at 501 Elliot Avenue West, #400, Seattle, Washington 98119-4240 (“
CTI ”); and Hope Heart Institute, a Washington non-profit corporation with offices at 1710 E. Jefferson, Seattle, Washington
98122 (“ The Hope ”).
- 1 -
A. The mission of The Hope is to advance the knowledge of heart and cardiovascular disease and treatment through
laboratory research, clinical study, publication and community education.
B. The mission of CTI is the treatment of cancer by developing safer, more effective cancer therapies.
C. The parties have concluded that it would be in their mutual best interests to enter into this Agreement to further their
respective missions by joint research and collaboration in the areas of cardiovascular and cancer research.
D. In consideration of rights to be granted to CTI hereunder with respect to Pre-Existing Inventions and Pre-Existing
Technology, and the options with respect to Hope Heart Inventions and Hope Heart Technology (all as defined
below), CTI is willing to grant The Hope a warrant to purchase common stock of CTI.
In consideration of the performance of the Research Program and the rights to be granted to CTI hereunder with
respect to Sponsored Research Inventions and Sponsored Research Technology (all as defined below) CTI is willing
to fund the Research Program.
In consideration of rights to be granted to CTI hereunder with respect to Hope Heart Inventions and Hope Heart
Technology (as defined below) for which CTI elects to receive a license, CTI is willing to pay certain running royalti